Quest will now offer dialysis-related clinical testing services to independent dialysis clinics
This is the group’s first NoC approval in Canada
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
Both these products will be manufactured at Lupin’s Injectable facility at Nagpur, India
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Subscribe To Our Newsletter & Stay Updated
